Pay in 4 interest-free payments of $28.26 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
OTS514 treatment reduced CD90-positive SCLC cells and showed higher cytotoxic effect against lung sphere-derived CSC-like SCLC cells
SR18662 induces apoptosis
InChi: InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2
and eliminate M
In vivo studies indicate that I-BET151 can provide survival benefit in two distinct mouse models of murine MLL–AF9 and human MLL–AF4 leukaemia
PFK-015 (UK-453061) OTS514 treatment reduced CD90-positive SCLCPFK 015 is a potent inhibitor of PFKFB3. The preliminary results in a U87GM xenograft model have shown that PFK 015 has comparable activity to Temozolomide. PFK 015 inhibits glucoseuptake by tumors. Product information CAS Number: 4382 63 2 Molecular Weight: 260. 29 Formula: C17H12N2O Synonym: PFK015 PFK 015 Chemical Name: (2E) 1 (pyridin 4 yl) 3 (quinolin 2 yl)prop 2 en 1 one Smiles: O=C( C=C C1=CC=C2C=CC=CC2=N1)C1C=CN=CC=1 InChiKey: UJJUKZPBUMCSJZ
US$ 270.00
US$ 270.00
US$ 270.00
US$ 270.00
US$ 5997.50
US$ 39.90